Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.

Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Berek JS, Chen LM, Cristea M, DeRosa M, ElNaggar AC, Gershenson DM, Gray HJ, Hakam A, Jain A, Johnston C, Leath CA III, Liu J, Mahdi H, Matei D, McHale M, McLean K, O'Malley DM, Penson RT, Percac-Lima S, Ratner E, Remmenga SW, Sabbatini P, Werner TL, Zsiros E, Burns JL, Engh AM.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):896-909. doi: 10.6004/jnccn.2019.0039.

PMID:
31390583
2.

Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genes.

Zhu Q, Zhang J, Chen Y, Hu Q, Shen H, Huang RY, Liu Q, Kaur J, Long M, Battaglia S, Eng KH, Lele SB, Zsiros E, Villella J, Lugade A, Yao S, Liu S, Moysich K, Odunsi KO.

Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32545. [Epub ahead of print]

PMID:
31265121
3.

Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium.

Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, DeFazio A; Australian Ovarian Cancer Study Group, Edwards R, Goode EL, Goodman MT, Høgdall E, Matsuo K, Mizuno M, Nagle CM, Ness RB, Paddock LE, Pearce CL, Risch HA, Rossing MA, Terry KL, Wu AH, Modugno F, Webb PM, Moysich KB; Ovarian Cancer Association Consortium.

Cancer Causes Control. 2019 May;30(5):537-547. doi: 10.1007/s10552-019-01157-3. Epub 2019 Mar 23.

4.

Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b.

Lin K, Qiang W, Zhu M, Ding Y, Shi Q, Chen X, Zsiros E, Wang K, Yang X, Kurita T, Xu EY.

Cell Rep. 2019 Feb 26;26(9):2434-2450.e6. doi: 10.1016/j.celrep.2019.01.111.

5.

Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.

Singel KL, Emmons TR, Khan ANH, Mayor PC, Shen S, Wong JT, Morrell K, Eng KH, Mark J, Bankert RB, Matsuzaki J, Koya RC, Blom AM, McLeish KR, Qu J, Ram S, Moysich KB, Abrams SI, Odunsi K, Zsiros E, Segal BH.

JCI Insight. 2019 Mar 7;4(5). pii: 122311. doi: 10.1172/jci.insight.122311. eCollection 2019 Mar 7.

6.

Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery.

Mark J, Argentieri DM, Gutierrez CA, Morrell K, Eng K, Hutson AD, Mayor P, Szender JB, Starbuck K, Lynam S, Blum B, Akers S, Lele S, Paragh G, Odunsi K, de Leon-Casasola O, Frederick PJ, Zsiros E.

JAMA Netw Open. 2018 Dec 7;1(8):e185452. doi: 10.1001/jamanetworkopen.2018.5452.

7.

Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer.

Starbuck KD, Szender JB, Duncan WD, Morrell K, Etter JL, Zsiros E, Odunsi K, Moysich K, Eng KH.

PLoS One. 2018 Nov 12;13(11):e0206913. doi: 10.1371/journal.pone.0206913. eCollection 2018.

8.

Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies.

Mayor P, Starbuck K, Zsiros E.

Gynecol Oncol. 2018 Aug;150(2):361-369. doi: 10.1016/j.ygyno.2018.05.024. Epub 2018 May 24. Review.

9.

Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study.

Eng KH, Szender JB, Etter JL, Kaur J, Poblete S, Huang RY, Zhu Q, Grzesik KA, Battaglia S, Cannioto R, Krolewski JJ, Zsiros E, Frederick PJ, Lele SB, Moysich KB, Odunsi KO.

PLoS Genet. 2018 Feb 15;14(2):e1007194. doi: 10.1371/journal.pgen.1007194. eCollection 2018 Feb.

10.

History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.

Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, Jordan SJ, Fasching PA, Beckmann MW, Risch HA, Rossing MA, Doherty JA, Chang-Claude J, Goodman MT, Dörk T, Edwards R, Modugno F, Ness RB, Matsuo K, Mizuno M, Karlan BY, Goode EL, Kjær SK, Høgdall E, Schildkraut JM, Terry KL, Cramer DW, Bandera EV, Paddock LE, Kiemeney LA, Massuger LFAG, Sutphen R, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Kupryjanczyk J, Jensen A, Webb PM, Moysich KB; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1470-1473. doi: 10.1158/1055-9965.EPI-17-0367.

11.

History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.

Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, Hillemanns P, Høgdall E, Jensen A, Jordan SJ, Karlan BY, Kjær SK, Klapdor R, Matsuo K, Mizuno M, Nagle CM, Odunsi K, Paddock L, Rossing MA, Schildkraut JM, Schmalfeldt B, Segal BH, Starbuck K, Terry KL, Webb PM, Zsiros E, Ness RB, Modugno F, Bandera EV, Chang-Claude J, Moysich KB.

Br J Cancer. 2017 Sep 26;117(7):1063-1069. doi: 10.1038/bjc.2017.267. Epub 2017 Aug 17.

12.

Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.

Eng KH, Morrell K, Starbuck K, Spring-Robinson C, Khan A, Cleason D, Akman L, Zsiros E, Odunsi K, Szender JB.

Gynecol Oncol. 2017 Jul;146(1):52-57. doi: 10.1016/j.ygyno.2017.05.005. Epub 2017 May 8.

13.

History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.

Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH, Odunsi K, Mayor P, Zsiros E, Schmalfeldt B, Klapdor R, Dӧrk T, Hillemanns P, Kelemen LE, Kӧbel M, Steed H, de Fazio A; Australian Ovarian Cancer Study Group, Jordan SJ, Nagle CM, Risch HA, Rossing MA, Doherty JA, Goodman MT, Edwards R, Matsuo K, Mizuno M, Karlan BY, Kjær SK, Høgdall E, Jensen A, Schildkraut JM, Terry KL, Cramer DW, Bandera EV, Paddock LE, Kiemeney LA, Massuger LF, Kupryjanczyk J, Berchuck A, Chang-Claude J, Diergaarde B, Webb PM, Moysich KB; Ovarian Cancer Association Consortium.

Cancer Causes Control. 2017 May;28(5):469-486. doi: 10.1007/s10552-017-0867-1. Epub 2017 Mar 14.

14.

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph JM, Mayor P, Abrams SI, Segal BH, Wallace PK, Soh KT, Zsiros E, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bjorge L, Bruegl A, Campbell IG, Campbell SP, Chenevix-Trench G, Cramer DW, Dansonka-Mieszkowska A, Dao F, Diergaarde B, Doerk T, Doherty JA, du Bois A, Eccles D, Engelholm SA, Fasching PA, Gayther SA, Gentry-Maharaj A, Glasspool RM, Goodman MT, Gronwald J, Harter P, Hein A, Heitz F, Hillemmanns P, Høgdall C, Høgdall EV, Huzarski T, Jensen A, Johnatty SE, Jung A, Karlan BY, Klapdor R, Kluz T, Konopka B, Kjær SK, Kupryjanczyk J, Lambrechts D, Lester J, Lubiński J, Levine DA, Lundvall L, McGuire V, McNeish IA, Menon U, Modugno F, Ness RB, Orsulic S, Paul J, Pearce CL, Pejovic T, Pharoah P, Ramus SJ, Rothstein J, Rossing MA, Rübner M, Schildkraut JM, Schmalfeldt B, Schwaab I, Siddiqui N, Sieh W, Sobiczewski P, Song H, Terry KL, Van Nieuwenhuysen E, Vanderstichele A, Vergote I, Walsh CS, Webb PM, Wentzensen N, Whittemore AS, Wu AH, Ziogas A, Odunsi K, Chang-Claude J, Goode EL, Moysich KB; Australian Ovarian Cancer Study.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):420-424. doi: 10.1158/1055-9965.EPI-16-0631. Epub 2016 Sep 27.

15.

Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy.

Zsiros E, Dangaj D, June CH, Kandalaft LE, Coukos G.

Oncoimmunology. 2015 Oct 19;5(5):e1062210. doi: 10.1080/2162402X.2015.1062210. eCollection 2016 May.

16.

Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer.

Zsiros E, Tsuji T, Odunsi K.

J Clin Oncol. 2015 May 10;33(14):1521-2. doi: 10.1200/JCO.2014.60.6566. Epub 2015 Apr 6. No abstract available.

PMID:
25847926
17.

International trends in electronic media communication among 11- to 15-year-olds in 30 countries from 2002 to 2010: association with ease of communication with friends of the opposite sex.

Boniel-Nissim M, Lenzi M, Zsiros E, de Matos MG, Gommans R, Harel-Fisch Y, Djalovski A, van der Sluijs W.

Eur J Public Health. 2015 Apr;25 Suppl 2:41-5. doi: 10.1093/eurpub/ckv025.

PMID:
25805786
18.

The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy.

Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, Hagemann IS, Levine BL, June CH, Zhang L, Wang E, Marincola FM, Bedognetti D, Powell DJ Jr, Tanyi J, Feldman MD, Kandalaft LE, Coukos G.

Clin Cancer Res. 2015 Jun 15;21(12):2840-50. doi: 10.1158/1078-0432.CCR-14-2777. Epub 2015 Feb 23.

19.

Supportive communication with parents moderates the negative effects of electronic media use on life satisfaction during adolescence.

Boniel-Nissim M, Tabak I, Mazur J, Borraccino A, Brooks F, Gommans R, van der Sluijs W, Zsiros E, Craig W, Harel-Fisch Y, Finne E.

Int J Public Health. 2015 Feb;60(2):189-98. doi: 10.1007/s00038-014-0636-9. Epub 2014 Dec 31.

PMID:
25549611
20.

Tumor-associated macrophages: co-conspirators and orchestrators of immune suppression in endometrial adenocarcinoma.

Zsiros E, Odunsi K.

Gynecol Oncol. 2014 Nov;135(2):173-5. doi: 10.1016/j.ygyno.2014.10.012. Epub 2014 Nov 15. No abstract available.

PMID:
25457976
21.

Immunotherapy for ovarian cancer: recent advances and perspectives.

Zsiros E, Tanyi J, Balint K, Kandalaft LE.

Curr Opin Oncol. 2014 Sep;26(5):492-500. doi: 10.1097/CCO.0000000000000111. Review.

PMID:
25036883
22.

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer.

Barber EL, Zsiros E, Lurain JR, Rademaker A, Schink JC, Neubauer NL.

J Gynecol Oncol. 2013 Jul;24(3):258-64. doi: 10.3802/jgo.2013.24.3.258. Epub 2013 Jul 4.

23.

Trends in educational differences in adolescent daily smoking across Europe, 2002-10.

de Looze M, ter Bogt T, Hublet A, Kuntsche E, Richter M, Zsiros E, Godeau E, Vollebergh W.

Eur J Public Health. 2013 Oct;23(5):846-52. doi: 10.1093/eurpub/ckt022. Epub 2013 Mar 13.

PMID:
23487549
24.

Intact rat superior mesenteric artery endothelium is an electrical syncytium and expresses strong inward rectifier K+ conductance.

Climent B, Zsiros E, Stankevicius E, de la Villa P, Panyi G, Simonsen U, García-Sacristán A, Rivera L.

Biochem Biophys Res Commun. 2011 Jul 8;410(3):501-7. doi: 10.1016/j.bbrc.2011.06.011. Epub 2011 Jun 7.

PMID:
21679686
25.

Developmental switch of the expression of ion channels in human dendritic cells.

Zsiros E, Kis-Toth K, Hajdu P, Gaspar R, Bielanska J, Felipe A, Rajnavolgyi E, Panyi G.

J Immunol. 2009 Oct 1;183(7):4483-92. doi: 10.4049/jimmunol.0803003. Epub 2009 Sep 11.

26.

The concentration dependent biphasic effect of leptin on endogenous cholesterol synthesis in human monocytes.

Balogh Z, Fóris G, Kosztáczky B, Paragh G Jr, Seres I, Zsíros E, Kónya G, Paragh G.

Peptides. 2007 Oct;28(10):2081-3. Epub 2007 Jul 12.

PMID:
17875346
27.

Leptin stimulates endogenous cholesterol synthesis in human monocytes: New role of an old player in atherosclerotic plaque formation. Leptin-induced increase in cholesterol synthesis.

Kosztáczky B, Fóris G, Paragh G Jr, Seres I, Zsiros E, Koncsos P, Balogh Z, Paragh G.

Int J Biochem Cell Biol. 2007;39(9):1637-45. Epub 2007 Apr 25.

PMID:
17560160
28.

Detection of citrate synthase-reacting autoantibodies after heart transplantation: an epitope mapping study.

Petrohai A, Nagy G, Bosze S, Hudecz F, Zsiros E, Paragh G, Nyárády Z, Németh P, Berki T.

Transpl Int. 2005 May;17(12):834-40. Epub 2005 Feb 15.

29.

New phenotypic, functional and electrophysiological characteristics of KG-1 cells.

Hajas G, Zsiros E, László T, Hajdú P, Somodi S, Réthi B, Gogolák P, Ludányi K, Panyi G, Rajnavölgyi E.

Immunol Lett. 2004 Mar 29;92(1-2):97-106.

PMID:
15081533
30.

Heterosis associated with genotype-environment interactions.

Griffing B, Zsiros E.

Genetics. 1971 Jul;68(3):443-55. No abstract available.

Supplemental Content

Loading ...
Support Center